1-3 of 3
Thomas J. Ervin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of Bendamustine, Bortezomib, and Rituximab in Patients with Previously Untreated Low Grade Lymphoma

Ian W. Flinn, MD PhD, Thomas J. Ervin, MD, Ralph V. Boccia, MD, Douglas B. Flora, MD, J. Daniel Cuevas, MD, Dana S. Thompson, MD, Dianna L. Shipley, MD, Jesus G. Berdeja, MD
Journal: Blood
Blood (2015) 126 (23): 1492.
https://doi.org/10.1182/blood.V126.23.1492.1492
Published: 2015
Journal Articles

Results of High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.

Kenneth A. Ault, MD, Delvyn Caedren Case, MD, Marjorie A. Boyd, MD, Thomas J. Ervin, MD, Frederick Aronson, MD, Kurt S. Ebrahim, DO, Jacquelyn A. Hedlund, MD
Journal: Blood
Blood (2006) 108 (11): 5438.
https://doi.org/10.1182/blood.V108.11.5438.5438
Published: 2006
Journal Articles

Results of High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.

Kenneth A. Ault, MD, Delvyn C. Case, Jr, MD, Marjorie A. Boyd, MD, Thomas J. Ervin, MD, Frederick R. Aronson, MD, Kurt S. Ebrahim, DO, Jaquelyn A. Hedlund, MD
Journal: Blood
Blood (2004) 104 (11): 5196.
https://doi.org/10.1182/blood.V104.11.5196.5196
Published: 2004